Trial intelligence / Profile preview

Ailixin pharmacokinetics with alcohol and dapoxetine in healthy Chinese males

CTR20232101Phase 4Completed

Sponsor
Tianjin Institute of Pharmaceutical Research
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aildenafil in erectile dysfunction (ED), sponsored by Tianjin Institute of Pharmaceutical Research. Started Jul 2023; status: completed.

02

Drugs

aildenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on CTR20232101.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20232101.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call